This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williamson, R
Right arrow Articles by Tomasz, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williamson, R
Right arrow Articles by Tomasz, A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1980 October; 18(4): 629-637

In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae.

R Williamson, R Hakenbeck and A Tomasz

ABSTRACT

The interactions of several beta-lactam antibiotics with the penicillin-binding proteins (PBPs) of Streptococcus pneumoniae have been studied using whole organisms treated with such antibiotics and subsequently with [3H]benzylpenicillin. Differences in chemical structure were shown to cause major and selective changes in the affinities of the beta-lactams for the PBPs Only 4 of the 28 compounds tested induced a specific morphological effect (enlargement of the equatorial region) under the particular conditions tested. In 12 of the 18 beta-lactams studied, a close correlation was found between the minimal inhibitory concentrations and the concentrations required to half-saturate PBP2b. However, such a correlation was no longer apparent when the bacteria were treated with the antibiotics at their minimal inhibitory concentrations. These findings are discussed in the context of various approaches that have been used to identify the growth-inhibitory targets of beta-lactam antibiotics in bacteria.


Antimicrob Agents Chemother. 1980 October; 18(4): 629-637




This article has been cited by other articles:

  • Qin, L., Masaki, H., Watanabe, K., Furumoto, A., Watanabe, H. (2007). Antimicrobial Susceptibility and Genetic Characteristics of Streptococcus pneumoniae Isolates Indicating Possible Nosocomial Transmission Routes in a Community Hospital in Japan. J. Clin. Microbiol. 45: 3701-3706 [Abstract] [Full Text]  
  • Rogers, P. D., Liu, T. T., Barker, K. S., Hilliard, G. M., English, B. K., Thornton, J., Swiatlo, E., McDaniel, L. S. (2007). Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J Antimicrob Chemother 59: 616-626 [Abstract] [Full Text]  
  • Haenni, M., Majcherczyk, P. A., Barblan, J.-L., Moreillon, P. (2006). Mutational Analysis of Class A and Class B Penicillin-Binding Proteins in Streptococcus gordonii. Antimicrob. Agents Chemother. 50: 4062-4069 [Abstract] [Full Text]  
  • Severin, A., Wu, S. W., Tabei, K., Tomasz, A. (2005). High-Level {beta}-Lactam Resistance and Cell Wall Synthesis Catalyzed by the mecA Homologue of Staphylococcus sciuri Introduced into Staphylococcus aureus. J. Bacteriol. 187: 6651-6658 [Abstract] [Full Text]  
  • Morlot, C., Pernot, L., Le Gouellec, A., Di Guilmi, A. M., Vernet, T., Dideberg, O., Dessen, A. (2005). Crystal Structure of a Peptidoglycan Synthesis Regulatory Factor (PBP3) from Streptococcus pneumoniae. J. Biol. Chem. 280: 15984-15991 [Abstract] [Full Text]  
  • Asahi, Y., Ubukata, K. (1998). Association of a Thr-371 Substitution in a Conserved Amino Acid Motif of Penicillin-Binding Protein 1A with Penicillin Resistance of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2267-2273 [Abstract] [Full Text]  
  • Sifaoui, F., Varon, E., Kitzis, M.-D., Gutmann, L. (1998). In Vitro Activity of Sanfetrinem and Affinity for the Penicillin-Binding Proteins of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 173-175 [Abstract] [Full Text]  
  • TOMASZ, A. (1982). Penicillin-Binding Proteins in Bacteria. ANN INTERN MED 96: 502-504 [Abstract]